Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,681.41
(
-0.52%
)
US TECH 100
24,051.20
(
-0.34%
)
Dow Jones
46,606.40
(
-0.82%
)
Brent Oil
105.73
(
5.05%
)
Bitcoin
71,284.42
(
-3.59%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jbog post# 110740

Saturday, 12/11/2010 2:44:07 PM

Saturday, December 11, 2010 2:44:07 PM

Post# of 257253

Pfizer would do its shareholders a favor by shutting down its basic research group, saving maybe $5B out the current $9 Billion it spends annually. (It'll still need the clinical trial group.) It then could use that $5 Bil to purchase its needed research.

Why are you so sure PFE could get more value for the $5B by outsourcing basic research?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now